Know What's Happening in Healthcare
Know What's Happening in Healthcare
FDA approves KRESLADI, first CIRM‑backed gene‑editing therapy
The FDA cleared KRESLADI, a gene‑editing treatment from Rocket Pharmaceuticals for severe leukocyte adhesion deficiency‑I in children, eliminating the need for a bone‑marrow donor. It is the first product directly funded by California’s Institute for Regenerative Medicine to receive approval.
Also developing:
By the numbers: Syneron Bio raises $150M Series B
Acting CDC Director Jay Bhattacharya told staff he will steer the agency toward stability after a year of mass layoffs, a shooting, and a leadership vacuum. He pledged to fill acting roles, depoliticize operations and restore morale as the 210‑day deadline to name a permanent director looms.
A Michigan state audit uncovered that the Department of Health and Human Services failed to adequately monitor an $82 million contract with Prime Therapeutics State Government Solutions, a pharmacy‑benefits manager for Medicaid. Over a seven‑and‑a‑half‑year period, oversight relied heavily on the...
Precigen (PGEN) reported fiscal Q4 2025 revenue of $9.7 million, up 149% year‑over‑year, and projected first‑quarter 2026 sales to exceed $18 million. The surge stems from the rapid commercial rollout of its FDA‑approved gene‑therapy Papzimius and broader payer coverage across the United...
OpenAI launched ChatGPT Health, a consumer AI that can ingest medical records, wearable data, and personal health history to give real‑time, context‑aware guidance. The platform serves 230 million weekly users asking health questions, exposing how primary‑care systems have failed to provide...
Bone‑growth stimulators, classified as Class III devices, sit at a volatile crossroads of reimbursement rules, medical necessity, and aggressive marketing. Recent enforcement actions reveal kickback schemes disguised as personal service agreements and template‑billing practices that generated over $1.1 million in fraudulent claims...
If you use the terminology “GLP-3” instead of GLP-1/GIP/Glucagon receptor agonist or at least triple agonist, I’m going to assume you don’t know much about these medicines.
As a medical school professor, I can tell you: the textbooks got this one wrong. We taught that once you have prostate cancer, exercise is nice but optional. New data says it may be the most powerful tool in your arsenal. 828...
The Echo Journal outlines a systematic approach to assessing atrial septal defects (ASDs) using echocardiography, emphasizing the three anatomical regions of the interatrial septum—central, inferior, and superior. It details how each region correlates with specific defect types, such as ostium...
Novocure disclosed topline Phase‑2 PANOVA‑4 data showing that Tumor‑Treating Fields (TTFields) combined with Tecentriq and gemcitabine/nab‑paclitaxel achieved a 74.4% disease‑control rate in metastatic pancreatic ductal adenocarcinoma (mPDAC). The trial, enrolling 78 patients, outperformed the historical MPACT control arm’s 48% DCR. Secondary...
Epic Systems remains the dominant electronic health record (EHR) vendor, powering more than 250 U.S. hospitals, but its market grip faces mounting criticism over cost, complexity, and data‑privacy practices. A Texas‑filed lawsuit, spearheaded by the state Attorney General, alleges Epic’s...
Starting July 1, the Lexington Fire Protection District will become the primary ambulance provider for the neighboring Octavia Fire Protection District, delivering basic life support services staffed by licensed EMTs. The agreement covers the communities of Anchor, Cropsey, Colfax and Cooksville....
The UK Defence Science and Technology Laboratory teamed with the US DARPA under the In the Moment program to test AI‑aligned battlefield medical triage. Trials in October 2025 at Merville Barracks and Brize Norton used VR scenarios where AI mimicked a...
A Nestlé‑backed randomized trial gave healthy men 714 mg nicotinamide and 19 mg pyridoxine daily for nine days after intense eccentric exercise. The B‑vitamin combo boosted muscle stem cell numbers by 29% and accelerated differentiation markers—MyoD+ cells rose 67%, myogenin+ cells 34%,...
The UK Advertising Standards Authority (ASA) has flagged three menopause‑focused supplement brands—Lunera, Minerva Wellness and Nova—for making unauthorized health claims in paid social media ads. The advertisements suggested the products could treat menopause symptoms such as weight gain, hot flushes,...
Pinnacle Medicines, a two‑year‑old biotech focused on oral peptide therapeutics, secured $89 million from a mix of U.S. and Chinese investors. The financing will fund its platform that converts injectable peptides into pill form, building on the recent success of Novo...
The 2026 pharmacy benefit manager (PBM) RFP season is shaping up to be one of the most consequential for employers, driven by sweeping state and federal reforms and soaring healthcare costs. Nearly two‑thirds of plan sponsors are already considering alternatives...
In this episode, Bruno Quinney highlights three breakthrough studies: Edinburgh researchers engineered E. coli to convert PET plastic waste into the Parkinson's drug L‑DOPA, offering a sustainable route to a vital medication; scientists identified the enzyme DHX8 as a key...
Otsuka Pharmaceutical presented Phase III VISIONARY trial data for Voyxact (sibeprenlimab‑szsi) in IgA nephropathy patients at risk of progression. At 48 weeks, 82.5% of patients receiving 400 mg subcutaneous Voyxact achieved negative microscopic hematuria versus 52.6% on placebo, with median time to...
Exazym®'s BOLD amplification technology boosts the sensitivity of a human cardiac troponin I sandwich ELISA by 180‑fold, lowering the detection limit to 0.07 pg/mL. The webinar presented by Cavidi’s Peter Stenlund shows how the method integrates into standard ELISA workflows with...
The International Menopause Society (IMS) has issued its first comprehensive overhaul of global menopause guidelines since 2016, delivering an evidence‑led framework developed by 38 experts and 27 contributors. The live, updateable document spans 30 sections covering symptoms, cardiometabolic health, bone...
India's health‑insurance premiums surged past ₹1.2 lakh crore (≈ $14.5 billion) in FY 2024‑25, marking a 9% year‑on‑year increase. The Insurance Regulatory and Development Authority of India (IRDAI) introduced tighter cashless claim timelines—one hour for pre‑authorisation and three hours for final approval—to speed...
The article exposes a systemic failure of accountability in pediatric home health care, where state caps on nursing hours leave families to shoulder massive unpaid caregiving burdens. Reporting serious safety violations to nursing boards often results in silence, highlighting a...
The escalation of the Iran conflict has throttled traffic through the Strait of Hormuz and crippled Gulf airport capacity, exposing a fragile pharmaceutical distribution network that relies on the Dubai hub. Air‑cargo rates are soaring while the region’s ability to...
The Laudio and AONL Spring 2026 report, based on a national dataset of nearly 100,000 RNs, shows Generation Z is the fastest‑growing nursing cohort and the only one still expanding. Gen Z nurses demand 2.5 times more frequent, meaningful manager interactions and...
A lot of midlife women are not failing weight loss advice. They are following advice that may be physiologically mismatched to this stage of life. In this episode of The Podcast by KevinMD, Marsha Shepherd Whitt challenges a message clinicians and patients...
The healthcare model moves to homeownership. Higher premiums for lower coverage. Now let's pause to consider who this adversely impacts the most. I suppose we should take consolation in the fact that those at the bottom were already priced out of home ownership.
In 2024 Canada recorded 16,499 medically assisted deaths, with Quebec responsible for more than a third of the total. The majority (99.99%) were active euthanasia cases using a three‑drug protocol, making MAID the fourth leading cause of death after cancer,...
Scholar Rock's anti-TGFb1 antibody clinical study with early data in oncology indications... minimal AEs and signs of durable efficacy in checkpoint-refractory patients. $SRRK https://t.co/8xsN4wtbMV
Measles in federal detention facility reaches the Texas public. My comments with @alexnguyen2311 @TexasTribune https://t.co/zaqrcEa4rC
Autoimmune drug development is moving upstream, targeting pathogenic immune cells rather than single cytokines. AnaptysBio’s Chief Medical Officer, Paul Lizzul, highlighted the company’s cell‑selective immunomodulation strategy, including CD122 antagonism that modulates both CD4 helper and CD8 cytotoxic T cells. Early‑phase...
Swiss‑based Kallisio has secured CE certification for its Stentra intraoral positioning system under the EU Medical Device Regulation 2017/745. The device, a patient‑specific 3‑D‑printed oral immobilizer, improves millimeter‑level accuracy in head‑and‑neck radiation therapy without altering existing treatment planning software or...
The U.S. Senate has advanced legislation that would fund expanded clinical trials of psychedelic therapies for veterans suffering from PTSD, depression and traumatic brain injury. The bill, backed by a bipartisan coalition, marks the first federal effort to systematically study...
A new UC Davis study of more than 13,000 U.S. adults shows that simple “high‑in” front‑of‑package labels help consumers spot added sugar, sodium or saturated fat faster than the FDA’s proposed low/medium/high rating box. The findings intensify calls for the agency...
Eli Lilly announced top‑line results from the Phase III TRANSCEND‑T2D‑1 trial, showing its investigational triple‑hormone agonist retatrutide reduced HbA1c by up to 2 percentage points and produced an average 16.8 % weight loss over 40 weeks. The data position retatrutide as a potential...
Atossa Therapeutics released its fourth‑quarter 2025 earnings and announced that the FDA granted Rare Pediatric Disease and Orphan Drug designations to its lead candidate (Z)-endoxifen for Duchenne muscular dystrophy. The company said the designations accelerate its rare‑disease strategy while it...
New Horizon Medical Solutions announced the appointment of Dr. Christine Grogan as Chief Commercial Officer, tasking her with expanding sales, marketing and partnership initiatives. The move underscores the fast‑growing health‑tech firm’s push to scale commercial operations amid rising demand for...
Dyadic (DYAI) posted Q4 2025 revenue of $3.1 million, a modest rise driven by COO Joseph P. Hazelton’s operational focus. The earnings call highlighted new product launches, global distribution deals and a growing reliance on grant‑linked R&D, offsetting a drop in...
A Sudanese army drone hit the El‑Daein Teaching Hospital in East Darfur, killing 70 people—including women, children and health workers—and wounding 146. The facility, which served more than two million residents, is now non‑functional, forcing patients to travel 160 km for...
Cuban doctors, earning roughly $16 a month, are forced to take side jobs to survive. The public health system faces severe shortages, with a surgery waiting list projected to swell to 160,000 by year‑end and over 300 pediatric operations each...
Corcept Therapeutics saw its shares climb almost 20% after the U.S. FDA gave the green light to Lifyorli in combination with nab‑paclitaxel for platinum‑resistant ovarian, fallopian tube and primary peritoneal cancers. The approval, based on a 381‑patient Rosella trial, validates...
Researchers at the Wyss Institute have created the first living robots, called neurobots, that develop functional nervous systems from implanted neuronal precursor cells. The neurobots, built from frog embryonic cells, self‑organize neural networks that reshape their morphology, boost motility, and...
A Johns Hopkins study of 173,168 admissions found that patients who board in emergency departments face a measurable risk of clinical deterioration. About 3.6% worsened within 48 hours, and nearly half of those events occurred while still in the ER....
Washington’s medical commission allowed OB‑GYN Dr. Mark Mulholland to keep seeing patients despite at least four sexual‑misconduct complaints filed between 2022 and 2025. The complaints describe invasive pelvic exams, sexually charged language, and inappropriate touching. Although the commission issued formal...
The UK Department of Health & Social Care has opened a consultation to apply an updated Nutrient Profiling Model (NPM) to the existing less‑healthy food (LHF) advertising restrictions, extending the ban to a wider range of high‑sugar products such as...
Hospital administrators are urged to adopt a digital‑first mindset to drive growth without adding complexity. By investing in online MHA education, leveraging data analytics, and automating routine tasks, they can improve efficiency, patient experience, and inter‑departmental communication. Secure, scalable platforms...
Red and near‑infrared light therapy is gaining traction as a non‑invasive wellness tool, leveraging specific wavelengths to stimulate mitochondria and boost cellular ATP production. Clinical‑grade full‑body panels now bring deep‑tissue penetration into homes, promising consistent results for skin health, pain...
From 26 March 2026 asylum‑seeking doctors, nurses and other qualified health professionals who have waited at least 12 months for an initial asylum decision will be allowed to work in any role listed on the Appendix Skilled Occupations at RQF level 6 or above,...
Biogen has signed an exclusive license with South Korean biotech Alteogen for ALT‑B4, a recombinant hyaluronidase enzyme that facilitates subcutaneous administration of biologics traditionally given intravenously. The agreement provides Alteogen with $20 million upfront, a $10 million payment upon initiation of a...
Heidi has introduced the Heidi Remote, a 21‑gram wearable microphone that provides up to 14 hours of battery life for AI‑assisted clinical documentation. The device operates independently of phones or Wi‑Fi, capturing audio offline and syncing later, and is built...
